Velocity Clinical Research

MARCH 7, 2024

Cromwell, MD, FAHA, FNLA, FAAFP, is board-certified in Family Medicine and Clinical Lipidology with over 20 years of clinical research experience. Currently, he serves on multiple journal editorial boards focusing on Cardiology and Lipidology and has been published in dozens of peer-reviewed publications, books, and abstracts.

Doctors 52

Doctors Doctor Clinical Research Clinical Trials 52

Velocity Clinical Research

DECEMBER 6, 2023

In addition to being one of Poland’s top recruiting sites in cardiology trials, ClinMedica also recruits patients across a broad range of therapeutic areas involving ambulatory medicine. Gackowska has led international teams dedicated to clinical trials management, product launch, market access, marketing, and sales.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

pharmaphorum

JULY 14, 2022

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Drugs 97

Drugs Sales Pharma Companies Cardiology 97

The Pharma Data

JUNE 28, 2021

The approval is based on the results of the pivotal Phase III VICTORIA trial, published in The New England Journal of Medicine (NEJM) in March 2020. Food and Drug Administration (FDA) in January 2021 and was recommended for marketing authorization by the Committee for Medicinal Products for Human Use (CHMP) in the EU in May 2021.

Cardiology 52

Cardiology Production Medicine Development 52

ACRP blog

JANUARY 24, 2023

Raising Community Awareness to Optimize Impact Nevada’s first integrated health system was created in June 2021 when an affiliation agreement was signed between Renown Health and the University of Nevada, Reno, School of Medicine. A strategic marketing plan deployed by research leaders succeeded in expanding enrollment.” “The

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

pharmaphorum

FEBRUARY 25, 2022

. “While Jardiance may not be effective in all patients with heart failure, this approval is a significant step forward for patients and our understanding of heart failure,” says Norman Stockbridge, MD, PhD, director of the Division of Cardiology and Nephrology in the FDA’s Center for Drug Evaluation and Research.

FDA Approval 101

FDA Approval HR Cardiology Drugs 101

The Pharma Data

OCTOBER 15, 2020

15, 2020 — CBD has been widely marketed as a cure-all for whatever ails you, and a new study finds many Americans are buying the sales pitch. Researchers tracking a Reddit forum on CBD found many folks discussing use of cannabidiol to treat conditions for which there are proven, safe and effective medicines and therapies.

Production 52

Production Medicine Doctor Doctors 52

The Pharma Data

MARCH 13, 2022

In connection with the acquisition, Arena’s shares of common stock will be delisted from the Nasdaq Global Select Market on or about March 11, 2022. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines.

Dermatology 52

Dermatology Cardiology Development Medicine 52

The Pharma Data

OCTOBER 14, 2020

“I was so frustrated forcing these yucky and sticky syrup medicines into my son when he was sick. We are focusing on the pediatric and geriatric market. Did you know one-third of the senior population can’t swallow tablets, and that medication non-adherence is the biggest problem in medicine? Visit [link].

Drugs 52

Drugs Allergies Cardiology Medicine 52

The Pharma Data

FEBRUARY 21, 2022

Tackling this challenge with advanced technologies and products, radiology is a key enabler to transform healthcare, expanding personalized medicine and improving outcomes for patients. We are taking bold steps into the future of drug development, investing strongly in areas at the forefront of the biomedical and technological revolution.

Radiology 52

Radiology Cardiology Development Production 52

pharmaphorum

JULY 6, 2021

Novartis has tried to get its marketing application for high cholesterol therapy inclisiran in the US back on track, after the FDA rejected it last year, by changing the factory that makes the drug. Novartis added inclisiran to its pipeline after buying The Medicines Company, which had licensed the drug from Alnylam, for $9.7

RNA 105

RNA Manufacturing Sales Marketing 105

The Pharma Data

DECEMBER 8, 2020

The company’s commercial priorities are three-fold: (1) Initially focusing its commercial efforts on rare diseases within its prolific neurology and cardiology franchises (2) pioneer new markets where there are no available treatments (3) create new standards of care where there has been a lack of innovation to optimize patient care.

Medicine 52

Medicine RNA Production Marketing 52

The Pharma Data

JULY 12, 2021

Bakris, MD, Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, USA and principal investigator of the FIDELIO-DKD trial. FDA has approved finerenone for marketing authorization in the U.S. There are more than 160 million patients living with CKD and T2D worldwide.

FDA Approval 52

FDA Approval Cardiology Medicine Trials 52

Delveinsight

DECEMBER 29, 2020

Myovant Sciences have decided to put their forces and efforts together to advance the Prostate cancer market as they announced their partnership deal to develop and market relugolix for prostate cancer and women’s health. . Relugolix is a once-daily, oral gonadotropin-release hormone (GnRH) receptor antagonist.

Trials 52

Trials Drugs Hormones Radiology 52

XTalks

JULY 19, 2021

“We successfully brought a medical-grade test, analogs of which are billed by the big players anywhere from $1,500 – $10,000, to a price point more accessible to the consumer market at $249.”. Bisignano added that, “It is time we finally made a medical-grade genetic test available as a proactive, preventative tool.

Genetics 98

Genetics Genome Genomics Gene 98

The Pharma Data

APRIL 1, 2021

Chairman, Department of Medicine, University of Mississippi. “When our specialties collaborate, we give our patients the best chance of success – which is highlighted in our professional society guidelines, including those from the American Diabetes Association and the American College of Cardiology.”

Nurses 52

Nurses Cardiology Medicine Insulin 52

The Pharma Data

JANUARY 20, 2021

Statistician: Dr. George Wells – Professor, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa and Director, Cardiovascular Research Methods Centre, University of Ottawa Heart Institute. Dr. Bennett is a board-certified cardiologist and board-eligible in critical care medicine.

Trials 52

Trials Cardiology Containment Development 52

The Pharma Data

NOVEMBER 2, 2020

market and congratulate all Chiesi team members and partners who supported the clinical process.”. Bronchitol is currently approved and marketed in Australia, Italy, Germany, Russia and several other countries. Your healthcare provider will use equipment to monitor you and have medicine ready if you have bronchospasm during the test.

FDA Approval 52

FDA Approval Bacteria Medicine Cardiology 52

pharmaphorum

DECEMBER 21, 2020

In a statement the Swiss pharma said that the FDA has not raised any concerns about the safety or efficacy of the drug, which Novartis added to its pipeline after buying The Medicines Company for $9.7 billion late last year. Payers had deemed the drugs to be too expensive and even price cuts failed to expand their use.

Drugs 52

Drugs RNA Manufacturing Licensing 52

pharmaphorum

OCTOBER 2, 2020

They have also been designed to improve the speed and consistency with which commercial research is delivered in the NHS and, by making it easier and quicker to deliver commercial research, the NPRCs will improve the UK’s competitiveness in the global market.

Clinical Trials 92

Clinical Trials Clinical Trials Life Science Clinical Research 92

pharmaphorum

MARCH 15, 2022

Major societies such as the European Society of cardiology (ESC) reported a 177% increase in attendees for its 2020 annual congress : 77,350 virtual attendees (logged-on) 2020 cf 27,946 physical attendees 2019. One important caveat here is that delegate registration fees were waived. Figure 1 What doctors say about virtual events . .

Doctor 105

Doctor Doctors Cardiology Allergies 105

Pharma Marketing Network

JANUARY 12, 2023

Advancing medicine, advancing patient care, and advancing equity in our global workforce are shared values of this year’s honorees driving transformational change and impact,” said Wendy White, interim CEO and 2022 STAR, HBA.

Life Science 52

Life Science Manufacturing Cardiology Development 52

pharmaphorum

OCTOBER 2, 2020

They have also been designed to improve the speed and consistency with which commercial research is delivered in the NHS and, by making it easier and quicker to deliver commercial research, the NPRCs will improve the UK’s competitiveness in the global market.

Clinical Trials 52

Clinical Trials Clinical Trials Life Science Clinical Research 52

The Pharma Data

DECEMBER 12, 2020

We look forward to welcoming our new colleagues at Alexion so that we can together build on our combined expertise in immunology and precision medicines to drive innovation that delivers life-changing medicines for more patients.” ” Ludwig Hantson , Ph.D., Strategic rationale.

Development 75

Development Regulation Medicine Containment 75

The Pharma Data

AUGUST 30, 2021

The findings from the FIGARO-DKD study were presented today during a Hot Line session at ESC Congress 2021, and simultaneously published in the New England Journal of Medicine. The cardiology franchise at Bayer already includes a number of products and several other compounds in various stages of preclinical and clinical development.

HR 52

HR Cardiology Clinical Trials Clinical Trials 52

The Pharma Data

AUGUST 29, 2020

Presented at the ESC Congress 2020, the annual meeting of the European Society of Cardiology, the analysis evaluated the efficacy and tolerability of inclisiran on top of a maximally tolerated dose of statins, in two studies of more than 2,300 patients (of which 1,164 were on inclisiran) from the Phase III trials.

Medicine 52

Medicine Containment Trials Production 52

The Pharma Data

SEPTEMBER 29, 2021

Heerspink, Professor of Clinical Trials and Personalized Medicine and a clinical pharmacologist/trialist at the Department of Clinical Pharmacy and Pharmacology at the University center Groningen, Netherlands, and Co-Chair of the study’s Executive Committee.

Clinical Development 52

Clinical Development Development Clinical Trials Clinical Trials 52

The Pharma Data

OCTOBER 28, 2021

Finerenone FIGARO-DKD study data: The results of Bayer’s Phase III study FIGARO-DKD, which evaluated finerenone in addition to standard of care in a broad patient population with CKD and T2D for CV outcomes, were presented at ESC Congress in August 2021 and simultaneously published in the New England Journal of Medicine.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Branding 52

pharmaphorum

JUNE 1, 2021

Novo Nordisk – which is already active in stem cell therapies with a candidate in early development for type 1 diabetes – is on the hook for up to $598 million in total licensing and milestone payments plus royalties on sales if HS-001 reaches the market.

Trials 138

Trials Licensing Licensing Development 138

The Pharma Data

NOVEMBER 4, 2020

Food and Drug Administration and European Medicine Agency as a potential therapy for patients with AL amyloidosis. Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines.

Containment 52

Containment Antibody Clinical Trials Clinical Trials 52

The Pharma Data

OCTOBER 25, 2020

“Abiomed has a long-established track record of bringing to market improved options to support physicians with innovative technology like Breethe, which is designed to provide advanced respiratory and cardiac support,” said Bartley Griffith, MD, the Hales Distinguished Professor of Surgery at University of Maryland, School of Medicine.

Cardiology 52

Cardiology FDA Approval Production Engineer 52

pharmaphorum

JANUARY 5, 2021

These are the crisis of healthcare system capacity and non COVID-19 patient backlog, and the economic crisis, still largely to come in impact, which will constrain healthcare spend, both public and private, across countries and have knock-on impacts for medicines spend.

Sales 105

Sales Marketing Production Vaccine 105

XTalks

SEPTEMBER 11, 2024

“Failure to study medications and other interventions in a broad sampling has led to women experiencing adverse effects from medications at nearly twice the rate of men ,” says Dr. Jaclyn Jansen, MD, MS, Medical Director of the Medical Department, General Medicine, Medpace. Precision medicine benefits breast cancer treatment.

Clinical Trials 103

Clinical Trials Clinical Trials Trials Hormones 103

The Pharma Data

JANUARY 12, 2021

The acquisition has the potential to advance the shared science-led mission of both companies to leverage complementary approaches to developing life-changing medicines. Based on AstraZeneca’s reference average ADR price of $54.14 This press release and further information about Alexion can be found at: www.alexion.com.

Containment 52

Containment Development Sales Production 52

pharmaphorum

FEBRUARY 26, 2021

Following World War II, Ethicon’s market share in surgical sutures rose from 15% to 70% worldwide. These two acquisitions enabled the company to gain a significant presence in the field of pharmaceutical medicines for the first time. In 1959, J&J acquired McNeil Laboratories in the US and also Cilag Chemie, AG in Europe.

Sales 126

Sales Production Pharma Companies Marketing 126

WCG Clinical

MAY 22, 2023

3 One finding was particularly interesting: Respondents who saw the pursuit of diversity as a scientific or ethical imperative felt more strongly about its importance than did those who considered diversity to be important primarily for regulatory or marketing reasons. Current Problems in Cardiology. New England Journal of Medicine.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Cardiology 52

The Pharma Data

NOVEMBER 4, 2020

Amarin’s decision to continue to invest in expanding the market for VASCEPA also reflects its confidence in its manufacturing processes, which the company has built over a decade to achieve consistent, high-quality, stable supply to support anticipated global demand. commercial team.

Sales 40

Sales Production Marketing Cardiology 40